Webinar
2 Feb 2024

How Primary Packaging can Accelerate Today's Drug Development & Approval Process

Bormioli Pharma has developed a solid and extensive patient-centric innovation program intended to advise the pharma industry along the entire drug development process, from early stage compatibility assessment up to the production of parts needed for drug fileing, clinical trials and commercialization. In the current healthcare domain where personalized medicine, biosimilars, gene-cell therapies, orphan drugs new formulation are becoming increasingly important, the choice and the development of the most appropriate pharmaceutical primary packaging is fundamental for success. Blending patient knowledge, an innovator DNA and leveraging at the same time on a robust industrial footprint is a distinctive capability and can be instrumental for building valuable co-partnership with the pharmaceutical industry. Bormioli Pharma will share details on its “Invents Department” and how biopharma companies leveraged on our services to accelerate the adoption of their biotechnology-based therapies.

Content provided by our supplier

Bormioli Pharma

  • IT
  • 2015
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Packaging & drug delivery

Other Content from Bormioli Pharma (4)

  • News CPHI Sustainability Trend Report: Towards a Greener Future

    CPHI releases its Sustainability Trend Report focusing on carbon emissions in the supply chain and working towards a greener future in the pharmaceutical industry.
  • Webinar Tomorrow’s Sustainable Packaging: Discovering Three New Routes

    Implementing sustainability in pharmaceutical packaging needs a two-way methodology: on the one hand, a scientific, data-driven approach to support today’s industrial solutions; on the other hand, a ground-breaking , never-stopping innovation research to anticipate future evolutions. With this Learning Lab, Bormioli Pharma discloses in preview the three drivers which are defining the Group’s mid-long strategy in terms of product sustainability, opening-up the debate to a qualified audience of pharmaceutical professionals. Why attending the Learning Lab? Having a clear picture of all the sustainable packaging solutions now available on the market; Grasping the occasion to be updated on the latest development directions; Clearly understanding opportunities to implement sustainable packaging in your business.
  • Webinar How to Combine Sustainable Packaging with Pharma Requirements: A Data-Driven Approach to Bridge the Gap.

    In this webinar, originally part of Pharmapack Europe 2022, Roberto Valenti, Head of Materials Development, Bormioli Pharma talks about combining sustainable packaging with pharma requirements. Strict regulatory frameworks and rigorous safety standards lead many to believe that pharma requirements and sustainability are not a simple match. Bormioli Pharma’s 15-year-long research into the field of sustainable pharma packaging demonstrates that data makes the difference. With this Learning Lab, participants gain useful insight into the latest eco-friendly packaging solutions for medicines, along with a scientific demonstration of the chemical safety of these containers and their positive impact on the environment.